ADARx Pharmaceuticals, Inc. (ADRX) shareholders
Close on Nov 17, 2026Market cap $1.48BP/E –Yield –
Ownership
Who owns ADARx Pharmaceuticals's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Orbimed Advisors LLC Joint filing with Orbimed Capital Gp Vii LLC (13.40%), Orbimed Advisors Israel Ii Ltd (8.70%) and 1 more | 14,913,764 | 14.00% | 13D (active) | Sep 28, 2026 |
| Yi Shi Joint filing with LAV Biosciences Fund V, L.P. (10.50%) | 11,858,655 | 11.10% | 13G (passive) | Sep 30, 2026 |
| SR One Capital Management, LLC Joint filing with Simeon George (9.30%), SR One Capital Fund I Aggregator, LP (5.20%) and 1 more | 9,936,661 | 9.30% | 13D (active) | Sep 28, 2026 |
| BCLS Fund III Investments, LP | 6,728,970 | 6.30% | 13G (passive) | Sep 24, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Zhen Li | President and CEO, Director, 10% owner | 5,861,199 | Sep 28, 2026 |
| Rui (NMN) Zhu | Chief Technology Officer | 2,511,943 | Sep 28, 2026 |
| Ryan Fisk | CFO and CBO | – | Sep 28, 2026 |
| Robert William Ackles | Chief People Officer | – | Sep 28, 2026 |
| Alan Robert MacLeod | Chief Scientific Officer | – | Sep 28, 2026 |
| Capital GP VII LLC OrbiMed | Director, 10% owner | – | Sep 30, 2026 |
| Advisors Llc Orbimed | Director, 10% owner | – | Sep 30, 2026 |
| Carl L. Gordon | Director, 10% owner | 7,127,019 | Sep 30, 2026 |
| Advisors Israel II Ltd OrbiMed | Director, 10% owner | – | Sep 30, 2026 |
| Erez Chimovits | Director | 8,974,061 | Sep 30, 2026 |
| Genesis GP LLC OrbiMed | Director, 10% owner | 588,235 | Sep 30, 2026 |
| OrbiMed Israel GP II, L.P. | Director, 10% owner | – | Sep 30, 2026 |
| Simeon George | Director, 10% owner | 7,133,690 | Sep 29, 2026 |
| Ying Huang | Director | – | Sep 24, 2026 |
| Mary Tagliaferri | Director | – | Sep 24, 2026 |
| LAV Biosciences Fund V, L.P. | 10% owner | – | Sep 29, 2026 |
| LAV Fund VI Opportunities, L.P. | 10% owner | – | Sep 29, 2026 |
| LAV Fund VI, L.P. | 10% owner | 11,191,720 | Sep 29, 2026 |
| Sr One Capital Management, Llc | 10% owner | 9,936,661 | Sep 29, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Buy | +588,235 | $17.00 | $10.00M | 588,235 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Buy | +61,516 | $17.00 | $1.05M | 9,292,025 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +10,690,530 | – | – | 10,690,530 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +2,000,962 | – | – | 12,691,492 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +769,601 | – | – | 13,461,093 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +256,448 | – | – | 9,230,509 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +513,067 | – | – | 8,974,061 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +1,333,975 | – | – | 8,460,994 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +7,127,019 | – | – | 7,127,019 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Buy | +300,249 | $17.00 | $5.10M | 14,325,529 |
| Genesis GP LLC OrbiMed Director, 10% owner | Sep 28, 2026 | Conversion | +564,187 | – | – | 14,025,280 |
| Erez Chimovits Director | Sep 28, 2026 | Conversion | +513,067 | – | – | 8,974,061 |
| Erez Chimovits Director | Sep 28, 2026 | Conversion | +256,448 | – | – | 9,230,509 |
| Erez Chimovits Director | Sep 28, 2026 | Buy | +61,516 | $17.00 | $1.05M | 9,292,025 |
| Erez Chimovits Director | Sep 28, 2026 | Conversion | +1,333,975 | – | – | 8,460,994 |
| Erez Chimovits Director | Sep 28, 2026 | Conversion | +7,127,019 | – | – | 7,127,019 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +7,127,019 | – | – | 7,127,019 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Buy | +61,516 | $17.00 | $1.05M | 9,292,025 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +256,448 | – | – | 9,230,509 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +513,067 | – | – | 8,974,061 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +1,333,975 | – | – | 8,460,994 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Buy | +588,235 | $17.00 | $10.00M | 588,235 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Buy | +300,249 | $17.00 | $5.10M | 14,325,529 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +564,187 | – | – | 14,025,280 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +769,601 | – | – | 13,461,093 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +2,000,962 | – | – | 12,691,492 |
| Carl L. Gordon Director, 10% owner | Sep 28, 2026 | Conversion | +10,690,530 | – | – | 10,690,530 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Buy | +592,593 | $17.00 | $10.07M | 5,554,094 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Buy | +592,593 | $17.00 | $10.07M | 592,593 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Conversion | +169,001 | – | – | 1,836,469 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Conversion | +1,667,468 | – | – | 1,667,468 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Buy | +414,814 | $17.00 | $7.05M | 1,953,505 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Conversion | +3,334,938 | – | – | 3,334,938 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Conversion | +1,113,666 | – | – | 4,448,604 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Conversion | +512,897 | – | – | 4,961,501 |
| Sr One Capital Management, Llc 10% owner | Sep 28, 2026 | Conversion | +1,538,691 | – | – | 1,538,691 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Conversion | +3,334,938 | – | – | 3,334,938 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Conversion | +1,113,666 | – | – | 4,448,604 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Conversion | +512,897 | – | – | 4,961,501 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Buy | +592,593 | $17.00 | $10.07M | 5,554,094 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Conversion | +1,538,691 | – | – | 1,538,691 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Buy | +414,814 | $17.00 | $7.05M | 1,953,505 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Conversion | +1,667,468 | – | – | 1,667,468 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Conversion | +169,001 | – | – | 1,836,469 |
| Simeon George Director, 10% owner | Sep 28, 2026 | Buy | +592,593 | $17.00 | $10.07M | 592,593 |
| LAV Fund VI, L.P. 10% owner | Sep 28, 2026 | Conversion | +1,667,469 | – | – | 10,576,244 |
| LAV Fund VI, L.P. 10% owner | Sep 28, 2026 | Conversion | +307,738 | – | – | 307,738 |
| LAV Fund VI, L.P. 10% owner | Sep 28, 2026 | Conversion | +153,868 | – | – | 11,243,179 |
| LAV Fund VI, L.P. 10% owner | Sep 28, 2026 | Conversion | +307,738 | – | – | 307,738 |
| LAV Fund VI, L.P. 10% owner | Sep 28, 2026 | Conversion | +8,908,775 | – | – | 8,908,775 |
| LAV Fund VI, L.P. 10% owner | Sep 28, 2026 | Conversion | +513,067 | – | – | 11,089,311 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 2 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of ADARx Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 142,681 shares on Sep 30, 2026 over the last 90 days.
See a number that looks wrong?